中證協:去年證券業盈利按年跌25.5% 投資收益倒退56%
中國證券業協會近期發布證券公司2022年度經營情況顯示,2022年,證券行業經營業績短期承壓,全行業共140間證券公司營業收入3,949.73億元人民幣(下同),按年下降21.38%;淨利潤1,423.01億元,按年下降25.54%;投資收益收益608.39億元,按年倒退55.94%,行業平均淨資產收益率為5.31%,按年下降2.53個百分點,證券投資業務成為拖累行業經營業績主要因素。
不過,得益於證券公司財富管理轉型,2022年,證券行業實現投資諮詢業務淨收入59.74億元,按年增長9.47%。行業總資產規模繼續提升,突破11萬億元,合規風控水平持續穩健。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.